Home
Conditions
Carcinoma, Intraductal, Noninfiltrating

Clinical trial condition

Carcinoma, Intraductal, Noninfiltrating

Explore clinical trials studying Carcinoma, Intraductal, Noninfiltrating. Study availability and eligibility vary by location and protocol.

218 public trials 40 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma, Intraductal, Noninfiltrating trial results

Completed

Patient Outcomes from Second Film-readers and Test Threshold Relaxation in Breast Screening

NCT04365114

Conditions: Adenocarcinoma, Breast Cancer, Breast Carcinoma In Situ, +13 more
Locations: Univesity of Warwick Coventry, Warwickshire, United Kingdom

View Trial Details

Completed

The Use of Deep Inspiration Breath Hold and Prone Irradiation to Decrease Cardiac Radiation Exposure

NCT03375892

Conditions: Adenocarcinoma, Breast Cancer, Breast Carcinoma In Situ, +14 more
Locations: Froedtert Hospital and Medical College of Wisconsin Milwaukee, Wisconsin, United States

View Trial Details

Completed

Testing an Active Form of Tamoxifen (4-hydroxytamoxifen) Delivered Through Breast Skin to Control Ductal Carcinoma in Situ (DCIS) of the Breast

NCT02993159

Conditions: Adenocarcinoma, Breast Carcinoma In Situ, Carcinoma, +8 more
Locations: Northwestern University Chicago, Illinois, United States

Saint Elizabeth Medical Center South Edgewood, Kentucky, United States

Mayo Clinic Rochester, Minnesota, United States

Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Assessing the Impact of the Microbiome on Breast Cancer Radiotherapy Toxicity

NCT04245150

Conditions: Adenocarcinoma, Breast Carcinoma In Situ, Carcinoma, +8 more
Locations: Cleveland Clinic, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Adjuvant Tamoxifen Compared With Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ

NCT00072462

Conditions: Adenocarcinoma, Breast Cancer, Breast Carcinoma In Situ, +12 more
Locations: Australia Newcastle, Australia

Austrian Breast & Colorectal Cancer Study Group Vienna, Austria

Belgium Leuven, Belgium

Chile Santiago, Chile

View all 97 locations

View Trial Details

Completed

Contrast-Enhanced MRI for the Characterization of Ductal Carcinoma in Situ (DCIS)

NCT00804128

Conditions: Adenocarcinoma, Breast Cancer, Breast Carcinoma In Situ, +12 more
Locations: University of California, San Francisco San Francisco, California, United States

View Trial Details

Completed

Effect of Aromatase Inhibitor Therapy on Blood Vessel Function in Postmenopausal Women With Breast Cancer

NCT00719966

Conditions: Adenocarcinoma, Breast Cancer, Breast Carcinoma In Situ, +12 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Abbreviated MRI Protocol: Initial Experience With Dotarem® (Gadoterate Meglumine)

NCT04341129

Conditions: Adenocarcinoma, Breast Cancer, Breast Carcinoma In Situ, +18 more
Locations: University of Chicago Medicine Chicago, Illinois, United States

View Trial Details

Completed

Nelipepimut-S Plus GM-CSF Vaccine Therapy in Treating Patients With Breast Cancer

NCT02636582

Conditions: Adenocarcinoma, Breast Carcinoma In Situ, Breast Ductal Carcinoma in Situ, +7 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center New York, United States

Thomas Jefferson University Hospital Philadelphia, Pennsylvania, United States

M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Soy Isoflavones Supplementation in Treating Women at High Risk For or With Breast Cancer

NCT01219075

Conditions: Adenocarcinoma, BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, +20 more
Locations: University of Southern California Los Angeles, California, United States

View Trial Details

Carcinoma, Intraductal, Noninfiltrating

Carcinoma, Intraductal, Noninfiltrating trial results

Related conditions